Toluene → HCID 178474140, compound
Reaction equation
[C:1]([NH:4][C:5]1[CH:6]=[C:7]([C:11]2[C:23]3[C:22]4[CH2:21][CH2:20][N:19](C(OC(C)(C)C)=O)[CH2:18][C:17]=4[CH:16]=[N:15][C:14]=3[NH:13][N:12]=2)[CH:8]=[CH:9][CH:10]=1)(=[O:3])[CH3:2].[F:31][C:32]([F:37])([F:36])[C:33]([OH:35])=[O:34].C1(C)C=CC=CC=1>ClCCl>[F:31][C:32]([F:37])([F:36])[C:33]([O-:35])=[O:34].[C:1]([NH:4][C:5]1[CH:6]=[C:7]([C:11]2[C:23]3[C:22]4[CH2:21][CH2:20][NH2+:19][CH2:18][C:17]=4[CH:16]=[N:15][C:14]=3[NH:13][N:12]=2)[CH:8]=[CH:9][CH:10]=1)(=[O:3])[CH3:2]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of tert-butyl 1-(3-acetamidophenyl)-8,9-dihydro-3H-pyrazolo[3,4-c][2,7]naphthyridine-7(6H)-carboxylate (0.108 g, 0.26 mmol) in dichloromethane (5 mL) was added trifluoroacetic acid (0.5 mL). The reaction was shaken overnight at room temperature. On completion, toluene (1 mL) was added and the solvent removed under reduced pressure. The crude product was purified using reverse phase HPLC (C-18 using TFA as a modifier) to give the desired product, 1-(3-acetamidophenyl)-6,7,8,9-tetrahydro-3H-pyrazolo[3,4-c][2,7]naphthyridin-7-ium 2,2,2-trifluoroacetate (0.042 g, 37%) as an off-white solid; M.p.=245° C. decomposition; 400 MHz 1H NMR (DMSO-d6) δ: 13.89 (br s, 1H), 10.13 (s, 1H), 9.16 (s, 1H), 8.43 (s, 1H), 8.01 (s, 1H), 7.56-7.5 (m, 1H), 7.48-7.4 (m, 1H), 7.28-7.22 (m, 1H), 4.43 (s, 2H), 3.4-3.3 (m, 2H), 3.1-3.0 (m, 2H), 2.08 (s, 3H); LCMS [M+H]: 308.
Workup
- customthe solvent removed under reduced pressure
- customThe crude product was purified
Sources & evidence
- ORD record
- ord-8e4ebf9c469a4ab1bb90069cd58767d4
- Source dataset
- uspto-grants-2012_09
- Patent number
- US08263610B2
Reaction notes
Loading…